|
KMID : 1104820180060020045
|
|
Journal of Digestive Cancer Research
2018 Volume.6 No. 2 p.45 ~ p.49
|
|
|
Emerging Treatment in Metastatic Colorectal Cancer
|
|
Kim Jae-Hyun
Park Seon-Ja
|
|
|
Abstract
|
|
|
|
Colorectal cancer(CRC) is the third most common cause of cancer-related death in the world. Although the long-term outcome of patients with metastatic CRC is still poor, target therapy including anti EGFR agents and anti VEGF agents and immunotherapy including anti PD-1 antibody and anti CTLA-4 antibody have shown clinical benefits in the treatment of patient with metastatic CRC. In the future, the personalized treatment strategy based on the clinical characteristics and biologic features of patients with metastatic CRC will be necessary. In this review, we summarized the mechanisms and clinical evidences of target therapy and immunotherapy, and the guideline of clinical practice in patients with metastatic CRC.
|
|
|
KEYWORD
|
|
|
Colorectal cancer, Target therapy, Immunotherapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|